Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Sydney 13 July 2015 July 7, 2015 • Category • Author Name

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Latest News

2021 AGM

November 30, 2021

2021 AGM Results of Meeting 2021 AGM Chairman’s Address 2021 AGM Presentation

Read More
Notice of Meeting

November 8, 2021

Notice of Meeting

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions